A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM

NCT05918107 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

MPM

Interventions

DRUG: PM8002
DRUG: Pemetrexed
DRUG: Cisplatin
DRUG: Carboplatin

Sponsor

Biotheus Inc.